PTKFY.US Kalbe Farma Tbk PT ADR

Healthcare Pharmaceuticals USA Stocks
8.35 USD
Close of Nov 17, 2026
7.26 14.28
Market cap
USD 1.89B
P/E
8.7x
P/B
1.41x
ROE
14.6%
Dividend yield
2.66%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is PTKFY.US undervalued?

Graham number
Price8.35
Graham value11.33
Discount26.3%

PTKFY.US trades 26.3% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Kalbe Farma Tbk PT ADR fundamental analysis

No fundamental analysis for Kalbe Farma Tbk PT ADR yet.

Kalbe Farma Tbk PT ADR stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Kalbe Farma Tbk PT ADR

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In…

Full company profile